FOUNDATIONAL TRIALS
Baszucki Group funds translational and clinical research that seeks to investigate the use of metabolic therapies for serious mental illness as well as predictive biomarkers and mechanisms of action.

First European Trial Shows Promise of Keto as a New Treatment for Bipolar
The study is the first to use neuroimaging to demonstrate that a ketogenic diet may improve brain metabolism in individuals with a bipolar disorder diagnosis. Increased ketone levels were correlated with participants’ improvements in mood, energy, impulsivity, and anxiety, with some describing the intervention as life-changing.

Stanford Study Shows Keto Improves Symptoms of Serious Mental Illness
Dr. Shebani Sethi’s 4-month clinical trial at Stanford of ketogenic diet for serious mental illness showed promising preliminary results indicating remission of bipolar disorder and schizophrenia in participants who adhered to the diet, as well as reversal of metabolic syndrome for those with the diagnosis.